has cleared its Investigational New Drug (IND) application for BL-M17D1, an antibody-drug conjugate (ADC) with a novel linker and payload technology. The IND supports the initiation of a phase 1 ...

The drug industry witnessed major policy changes during Joe Biden's four-year term as U.S. President, including the historic ...

Sunvozertinib has shown promising results in patients with non–small cell lung cancer with an EGFR exon 20 insertion mutation ...

The path from a scientist’s initial idea to a new medicine that can save lives is a complex and often lengthy process. It ...

Excitement is building around a new weight loss drug, CagriSema, which is expected to surpass the effects of popular drugs ...

逸达(6576)向美国食品药物管理局(FDA)递交甲磺酸亮丙瑞林(leuprolide mesylate)前列腺癌新剂型新药 CAMCEVI三个月缓释注射剂新药查验登记申请(New Drug Application, NDA)。逸达希望能在2025年取得FDA核发药证，2026 ...

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for donidalorsen, an investigational ...

has lifted the clinical hold on the investigational new drug application for the Phase 1 clinical trial evaluating OCU200, a recombinant fusion protein consisting of tumstatin and transferrin, for ...

If Kevin Roberts, the author of the extreme conservative Project 2025 “blueprint” for a second Trump term, is granted an ...

The ballot decisions Tuesday point to voter concerns that drug policies have drifted too far to the left, according to policy ...

A drug against fungal infections in cancer patients can last twice as long in people with obesity, and may make chemotherapy ...